Table 1. Comparison of demographics and comorbidity between with and without respiratory tuberculosis cohorts.

	Respiratory tuberculosis
	No (N = 13220)		Yes (N = 6612)
	n	%	n	%	p-value
Sex					0.99
Women	4008	30.3	2004	30.3
Men	9212	69.7	4608	69.7
Age, year					0.99
<35	2274	17.2	1137	17.2
35–65	5196	39.3	2598	39.3
≥65	5750	43.5	2877	43.5
Mean (SD)#	56.7	20.2	56.9	20.3	0.64
Occupation					<0.001
White collar	5685	43.0	2468	37.3
Blue collar	4839	36.6	2641	39.9
Others	2696	20.4	1503	22.7
Comorbidity
Hyperlipidemia	3439	26.0	1576	23.8	<0.001
Hypertension	6446	48.8	3283	49.7	0.24
Diabetes	2909	22.0	1793	27.1	<0.001
Pneumonia	4712	35.6	4019	60.8	<0.001
Live cirrhosis	3565	27.0	2376	35.9	<0.001
IHD	3597	27.2	2038	30.8	<0.001
Stroke	3319	25.1	1806	27.3	<0.001
COPD	5793	43.8	4982	75.4	<0.001
ESRD	183	1.38	170	2.57	<0.001
Alcohol-related illness	374	2.83	447	6.76	<0.001
Hyperparathyroidism	12	0.09	18	0.27	0.002
Celiac disease	0	0.00	1	0.02	-
Chron’s disease	236	1.79	133	2.01	0.27
Lower body weight	323	2.44	286	4.33	<0.001
Treatment
Oral steroid	4340	32.8	3402	51.5	<0.001
Bisphosphonates	76	0.57	101	1.53	<0.001
HRT	1218	9.21	651	9.85	0.15
Vitamin D supplements	21	0.16	12	0.18	0.71
Aromatase inhibitors	13	0.10	10	0.15	0.30

Chi-square test; ^# Student’s t-test; White collar: civil services, institution workers, enterprise, business and industrial administration personnel; Blue collar: farmers, fishermen, vendors, and industrial laborers; Others: retired, unemployed, and low-income populations; HRT, Hormone Replacement Therapy; IHD, ischemia heart disease; COPD, chronic obstructive pulmonary disease; ESRD, end-stage renal disease